Online citations, reference lists, and bibliographies.
← Back to Search

Oral Megadose Methylprednisolone Versus Intravenous Immunoglobulin For Acute Childhood Idiopathic Thrombocytopenic Purpura.

Ş. Ozsoylu, T. Saylı, G. Oztürk
Published 1993 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Twenty children with acute idiopathic thrombocytopenic purpura (ITP) were randomized to receive either oral megadose methylprednisolone (MDMP) or intravenous immunoglobulin G (IV IgG). Normal platelet counts (> or = 150 x 10(9)/l) were obtained in 6 patients of each group in 3 days and in 8 and 9 patients treated with oral MDMP and with IV IgG within 1 week, respectively. It is concluded that oral MDMP could easily be used for the early elevation of platelet counts, which is important for ITP treatment.
This paper references
10.1152/JAPPL.1950.3.6.365
Morphology and enumeration of human blood platelets.
G. Brecher (1950)
10.1016/S0140-6736(75)90888-0
HOME BLOOD-PRESSURE RECORDING
S. Julius (1975)
10.1001/ARCHPEDI.1977.02120160114019
Childhood Idiopathic Thrombocytopenic Purpura: To Treat or Not To Treat
W. Zuelzer (1977)
10.1016/S0140-6736(81)92400-4
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
P. Imbach (1981)
10.1097/00043426-198406020-00008
Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study.
J. Sartorius (1984)
10.1097/00043426-198406020-00009
Intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP) in childhood.
P. Imbach (1984)
10.1016/S0022-3476(85)80231-6
Treatment of acute idiopathic thrombocytopenia of childhood with intravenous infusions of gammaglobulin.
J. Bussel (1985)
10.1016/S0140-6736(85)90400-3
INTRAVENOUS IMMUNOGLOBULIN VERSUS ORAL CORTICOSTEROIDS IN ACUTE IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD
P. Imbach (1985)
10.1016/S0022-3476(88)80654-1
Pulse methylprednisolone therapy for acute childhood idiopathic thrombocytopenic purpura.
J. van Hoff (1988)
10.1111/j.1600-0609.1989.tb01466.x
High‐dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura
Ş. Özsoylu (1989)
10.3109/08880019009033409
Infantile idiopathic thrombocytopenic purpura.
A. Ballin (1990)
10.3109/08880019109028816
Idiopathic Thrombocytopenic Purpura in Infants
Ş. Özsoylu (1991)
10.1182/BLOOD.V77.8.1856.BLOODJOURNAL7781856
Oral megadose methylprednisolone for childhood acute idiopathic thrombocytopenic purpura.
S. Ozsoylu (1991)
10.1016/S0168-8278(05)80422-2
To treat or not to treat?: The judicious use of interferon-α-2a for the treatment of chronic hepatitis B
J. Ryff (1993)



This paper is referenced by
10.1182/bloodadvances.2019000966
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
C. Neunert (2019)
10.2174/1573396315666191023122542
First line treatments for newly diagnosed primary immune thrombocytopenia in children: a systematic review and network meta-analysis.
David Orlando Acero-Garcés (2019)
10.5350/SEMB.20171130112516
Use of Single- or Two-dose Pulse Methylprednisolone in the Treatment of Acute Immune Thrombocytopenic Purpura
A. Turhan (2018)
10.18203/2349-3291.IJCP20173770
High dose, short course prednisolone for acute idiopathic thrombocytopenic purpura (ITP) in children
Aparna Jayaraman (2017)
10.5045/br.2016.51.4.261
Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia
Musa Cura (2016)
10.15436/2381-1404.16.011
Influence of Intravenous Immunoglobulin and Methylprednisolone on Cytokines secreted by T Lymphocyte in Children Primary Immune Thrombocytopenia 1
Jingyao Ma (2016)
Immune thrombocytopenia in children
J. Roganović (2015)
10.3109/08880018.2015.1040931
Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years
I. Yıldız (2015)
10.1007/s00431-013-2254-6
Clinical practice: immune thrombocytopenia in paediatrics
V. Labarque (2013)
10.1111/j.1423-0410.2012.01636.x
Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions
T. Kühne (2013)
Management of immune thrombocytopenic purpura: an update.
Rajasekharan P Warrier (2012)
10.4274/TPA.1659
2011 yılında çocukluk çağı immün trombositopenik purpura hastalığı izlem ve tedavisinde değişiklikler
T. Celkan (2012)
Evidence-Based Emergent Management Of Bleeding Disorders
Katherine Fullerton (2011)
10.1182/blood-2009-06-225565
International consensus report on the investigation and management of primary immune thrombocytopenia.
D. Provan (2010)
primary immune thrombocytopenia International consensus report on the investigation and management of
Miguel A. Sanz (2010)
10.1016/j.hoc.2009.11.004
Childhood immune thrombocytopenic purpura: diagnosis and management.
V. Blanchette (2010)
Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
S. Yetgin (2010)
10.1080/08880010903044540
CLINICAL FEATURES, TREATMENT RESPONSES, AND OUTCOME OF CHILDREN WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA
F. Demircioğlu (2009)
Coagulation parameters in children with acute immun e thrombocytopenic purpura
Anabilim Dalı-Bornova (2009)
10.1182/blood-2008-07-162503
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
F. Rodeghiero (2009)
10.1111/j.1365-2141.2009.07743.x
Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS)
R. Tamminga (2009)
an international working group immune thrombocytopenic purpura of adults and children: report from Standardization of terminology, definitions and outcome criteria in
M. Ruggeri (2009)
10.1007/s12098-008-0137-z
Immune thrombocytopenic purpura
V. Gupta (2008)
10.1016/j.pcl.2008.01.009
Childhood immune thrombocytopenic purpura: diagnosis and management.
V. Blanchette (2008)
Supporting Informed Decisions Polyclonal Intravenous Immunoglobulin in Patients with Immune Thrombocytopenic Purpura : Clinical Systematic
Stella Chen (2008)
10.1182/BLOOD-2005-12-015222
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience.
M. G. Mazzucconi (2007)
10.1016/J.TMRV.2007.01.001
Guidelines on the use of intravenous immune globulin for hematologic conditions.
D. Anderson (2007)
10.1097/MPH.0b013e3180335be0
Comparison of Megadose Methylprednisolone Versus Conventional Dose Prednisolone in Hematologic Disorders
S. Yetgin (2007)
Evaluation of clinical characteristics, diagnosis and management in childhood immune thrombocytopenic purpura: a single center's experience.
U. Koçak (2007)
10.1002/pbc.20830
A cost‐utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP)
Sarah H. O'Brien (2007)
10.1007/s00112-006-1350-3
Strategien zur Behandlung von Thrombozytopenien im Kindesalter
W. Ebell (2006)
10.1016/J.JPEDS.2005.04.032
Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials.
C. Beck (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar